Skip to content
Govbase
Govbase
Congress·In Progress·H.R. 5160

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Bone Marrow and Cord Blood Transplant Funding

Part of: Stem Cell Therapeutic and Research Reauthorization Act

Stalled

No legislative action in over 90 days.

This bill is currently in the early stages of the legislative process after being introduced in the House. It has been sent to the House Committee on Energy and Commerce for review. No further actions are scheduled at this time.

Part of: story →

Legislative Progress

House
Senate
President
Law
Very likely to pass

This program has a long history of bipartisan support because it helps save lives through transplants. It is a routine update to a popular and successful health program.

Key Points

  • This bill continues a national program that helps people find bone marrow and cord blood donors for life-saving transplants. It specifically funds the national registry that doctors use to match patients with donors.
  • The plan increases federal funding to 33 million dollars each year from 2027 through 2031. This money helps maintain the database and supports research into using stem cells to treat serious diseases.
  • It also extends a program that collects and stores umbilical cord blood. Cord blood is used to treat blood cancers and other disorders when a bone marrow match is not available.
  • This policy is important for thousands of Americans with leukemia or other blood diseases who cannot find a donor match within their own families. It ensures the national system stays updated and accessible for patients in need.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

4 milestones7 actions
May 21, 2026House

Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.

May 21, 2026House

Committee Consideration and Mark-up Session Held

May 13, 2026House

Forwarded by Subcommittee to Full Committee by Voice Vote.

May 13, 2026House

Subcommittee Consideration and Mark-up Session Held

Sep 4, 2025House

Referred to the House Committee on Energy and Commerce.

Votes

No votes have been recorded for this legislation yet.

News

No related news coverage found for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Bill NumberHR 5160
Congress119th Congress
ChamberHouse of Representatives
Latest ActionOrdered to be Reported (Amended) by the Yeas and Nays: 48 - 0.

Sponsor

Cosponsors

(19)
D: 10R: 9

Analysis generated by AI. Always verify with official sources.